| Celiac plexus neurolysis/splanchnic nerve neurolysis | Phenol saddle block | Epidural infusions of local anesthetic combined with opioids | Intrathecal analgesia | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | |
Background | ||||||||||||
Sex | ||||||||||||
 Male | REFERENCE |  | 0.066 | - |  | - | - |  | - | - |  | - |
 Female | 0.658 | 0.42-1.03 |  | - | - |  | - | - |  | - | - |  |
Number of cancer patients with pain treated annually | ||||||||||||
 0 | REFERENCE |  | <0.001* | REFERENCE |  | <0.001* | REFERENCE |  | <0.001* | REFERENCE |  | <0.001* |
 1-9 | 3.72 | 1.84-7.51 |  | 4.14 | 2.15-7.97 |  | 4.94 | 2.54-9.60 |  | 2.74 | 1.38-5.44 |  |
 10-49 | 5.92 | 2.84-12.32 |  | 7.03 | 3.47-14.23 |  | 5.65 | 2.71-11.82 |  | 6.09 | 2.99-12.41 |  |
 ≥50 | 5.77 | 2.68-12.42 |  | 8.02 | 3.80-16.92 |  | 5.13 | 2.38-11.08 |  | 4.11 | 1.98-8.52 |  |
Working facility | ||||||||||||
 Designated cancer hospital/university hospital | REFERENCE |  | 0.599 | REFERENCE |  | 0.04* | - |  | - | - |  | - |
 Other | 1.12 | 0.73-1.74 |  | 1.58 | 1.02-2.43 |  | - | - |  | - | - |  |
Main workplace | ||||||||||||
 Ward/outpatient clinic | REFERENCE |  | 0.035* | REFERENCE |  | 0.959 | REFERENCE |  | 0.199 | REFERENCE |  | 0.387 |
 Operating room | 0.57 | 0.36-0.90 |  | 1.05 | 0.65-1.70 |  | 1.12 | 0.62-2.02 |  | 0.77 | 0.50-1.20 |  |
 Other | 0.37 | 0.09-1.49 |  | 1.18 | 0.31-4.49 |  | 0.34 | 0.09-1.28 |  | 1.51 | 0.35-6.49 |  |
Barriers | ||||||||||||
Difficult to gain experience and acquire skills due to the limited number of cases | ||||||||||||
 Agree | REFERENCE |  | <0.001* | REFERENCE |  | <0.001* | REFERENCE |  | 0.006* | REFERENCE |  | <0.001* |
 Other | 2.67 | 1.76-4.05 |  | 2.71 | 1.72-4.27 |  | 3.29 | 1.41-7.66 |  | 2.31 | 1.47-3.63 |  |
Difficult to treat patients who require the procedure due to a lack of time | ||||||||||||
 Agree | REFERENCE |  | 0.004* | REFERENCE |  | 0.01* | REFERENCE |  | 0.139 | REFERENCE |  | 0.318 |
 Other | 2.13 | 1.28-3.55 |  | 2.22 | 1.21-4.10 |  | 1.74 | 0.84-3.63 |  | 1.37 | 0.740-2.54 |  |
Difficult to communicate with other departments when implementing the procedure | ||||||||||||
 Agree | REFERENCE |  | 0.455 | REFERENCE |  | 0.956 | REFERENCE |  | 0.343 | REFERENCE |  | 0.96 |
 Other | 0.77 | 0.39-1.52 |  | 0.98 | 0.43-2.24 |  | 1.62 | 0.60-4.38 |  | 0.98 | 0.48-2.01 |  |
Implementation at our facility is not permitted | ||||||||||||
 Agree | REFERENCE |  | 0.009* | REFERENCE |  | 0.002* | REFERENCE |  | 0.193 | REFERENCE |  | 0.001* |
 Other | 4.20 | 1.44-12.25 |  | 5.53 | 1.84-16.63 |  | 2.38 | 0.64-8.79 |  | 7.77 | 2.22-27.11 |  |
Dispensing and using phenol glycerin are not permitted by the Ethics Committee or Regulatory Committee in our facility | ||||||||||||
 Agree | - | - |  | REFERENCE |  | 0.402 | - |  | - | - |  | - |
 Other | - | - |  | 1.28 | 0.72-2.25 |  | - | - |  | - | - |  |